• Loading stock data...

Financial News

Aldeyra Therapeutics Inc (NASDAQ:ALDX) Unveils Positive Results From Phase 2A Clinical Trial For Dry...

Aldeyra Therapeutics Inc (NASDAQ:ALDX) announced recently the positive results from its Phase 2a clinical trial of topical ocular (ADX-102) for treatment of patients with...

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Stock Falls After HCV Agreement With Johnson & Johnson (NYSE:JNJ)...

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares dropped 20% lower at the beginning of the week immediately after announcing that its hepatitis C partnership with Johnson...

Celldex Therapeutics, Inc. (NASDAQ:CLDX) Chief Medical Officer Resigns

Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced the resignation of the Executive Vice President and Chief Medical Officer (CMO), Thomas Davis, effective September 29. Anthony Marucci,...

Marinus Pharmaceuticals Inc (NASDAQ:MRNS) Stock Increases On Successful Phase II Ganaxolone Study

Marinus Pharmaceuticals Inc (NASDAQ:MRNS) announced the successful completion of Phase II Epilepsy study after examining the potential candidate, ganaxolone, for treatment of patients suffering...

Antares Pharma Inc (NASDAQ:ATRS) Announces Positive Phase III Trials That Support Xyosted Approval

Antares Pharma Inc (NASDAQ:ATRS) announced recently the positive Phase III trials that may support the approval of Xyosted , which was initially known as...

Signup To Receive Our E-Alerts on the Market’s Latest Trends in Cannabis, Energy, Health Care, Metals & Technology.

X